Repository of Research and Investigative Information

Repository of Research and Investigative Information

Hormozgan University of Medical Sciences

Relationship between selenium and prostate cancer risk; systematic review and meta-analysis and meta-regression

(2016) Relationship between selenium and prostate cancer risk; systematic review and meta-analysis and meta-regression. INTERNATIONAL JOURNAL OF MEDICAL RESEARCH & HEALTH SCIENCES.

[img] Text
relationship-between-selenium-and-prostate-cancer-risk-systematic-review-and-metaanalysis-and-metaregression.pdf

Download (910B)

Official URL: http://www.ijmrhs.com/archive/ijmrhs-volume-5-issu...

Abstract

Abstract Prostate cancer is one of the five most common cancers in men. It is suspected that selenium protect or exacerbate the risk of prostate cancer. The aim of this study was to determine the association between prostate cancer risk and selenium in the serum, toenail and supplements. So it was tried to do a systematic review and meta-analysis and meta-regression of 22 studies (5 toenail studies, 14 serum studies and 3 supplements studies) in order to obtain detailed results of these studies' data. Meta-regression results showed that location of study (p value < 0.001), type of study (p value = 0.04) and age (p value = 0.008) have significant effects on heterogeneity. There was no publication bias in studies (Begger's test: z-value = 1.98; P value=0.067). In general, unlike selenium supplements [OR=0.86 (CI: 0.7-1.06, P value=0.15], selenium increase in serum [OR=0.76 (0.59-0.99, P value= 0.04] and toenail [OR=0.58 (0.4-0.86, P value=0.01] significantly decreased the risk of prostate cancer by % 24 and 42 %. In general, the odds ratio between prostate cancer caused by selenium in the random effect model OR: 0.71 (CI: 0.590.86%, P value < 0.001) and heterogeneity was moderate (I-2 = 70.6%, P value < 0.001). The results of this study supported the lowering effect of selenium in serum and toenail on the risk of prostate cancer.

Item Type: Article
Keywords: Selenium; Prostate Cancer; Serum; Toenail; Supplements; Meta-analysis and Meta-regressionPREVENTION TRIAL SELECT; SERUM SELENIUM; VITAMIN-E; NUTRITIONAL PREVENTION; ALPHA-TOCOPHEROL; SELENOPROTEIN-P; SUBSEQUENT RISK; BETA-CAROTENE; HUMAN HEALTH; SUPPLEMENTATION
Subjects: QZ Pathology > QZ 200-380 Neoplasms
WJ Urogenital System > WJ 700-875 Male Genitalia
Depositing User: مهندس هدی فهیم پور
URI: http://eprints.hums.ac.ir/id/eprint/5049

Actions (login required)

View Item View Item